| NP49425 Generic and Biosimilar Transition Medicines | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| NP90425 Faricimab (Vabysmo®) | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| Trastuzumab and Rituximab Subcut | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| NP40725 Erythropoietin Stimulating Agents | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| NP47725a Emicizumab (Indication Specific) | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| NP41125 Immunosuppressant Medicines | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| All other psychiatry and neurology medicines | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| Rituximab Subcut | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| Trastuzumab (Herceptin®) 600mg/5ml solution for Injection | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| Range Generic & Biosimilar Cancer Medicines (unranked) | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |